Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1965 May;44(5):860–869. doi: 10.1172/JCI105198

The Liver and Postheparin Plasma Lipolytic Activity in Dog and Man*

Robert E Condon 1,†, Hillel Tobias 1,‡, Dharam V Datta 1,§
PMCID: PMC292562  PMID: 14276143

Full text

PDF
860

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anfinsen C. B., Boyle E., Brown R. K. The Role of Heparin in Lipoprotein Metabolism. Science. 1952 May 30;115(2996):583–586. doi: 10.1126/science.115.2996.583. [DOI] [PubMed] [Google Scholar]
  2. BARCLAY M., GARFINKEL E., TEREBUS-KEKISH O., SHAH E. B., DEGUIA M., BARCLAY R. K., SKIPSKI V. P. Properties of lipoprotein lipase extracted from livers of normal rats and livers and tumors of rats bearing Walker carcinosarcoma 256. Arch Biochem Biophys. 1962 Sep;98:397–405. doi: 10.1016/0003-9861(62)90204-7. [DOI] [PubMed] [Google Scholar]
  3. BORGSTROM B., JORDAN P. Metabolism of chylomicron glyceride as studied by C14-glycerol-C14-palmitic acid labeled chylomicrons. Acta Soc Med Ups. 1959;64:185–193. [PubMed] [Google Scholar]
  4. CONNOR W. E., ECKSTEIN J. W. The removal of lipoprotein lipase from the blood by the normal and diseased liver. J Clin Invest. 1959 Oct;38:1746–1755. doi: 10.1172/JCI103953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CONSTANTINIDES P., SO Y., JOHNSTONE F. R. Role of liver and kidney in development of heparin-induced lipemia clearing activity. Proc Soc Exp Biol Med. 1959 Feb;100(2):262–264. doi: 10.3181/00379727-100-24593. [DOI] [PubMed] [Google Scholar]
  6. DATTA D. V. Post-heparin plasma lipoprote in lipase levels in cirrhosis of the liver. Proc Soc Exp Biol Med. 1963 Apr;112:1006–1008. doi: 10.3181/00379727-112-28235. [DOI] [PubMed] [Google Scholar]
  7. FRASER J. R., LOVELL R. R., NESTEL P. J. The production of lipolytic activity in the human forearm in response to heparin. Clin Sci. 1961 Jun;20:351–356. [PubMed] [Google Scholar]
  8. FREDRICKSON D. S., ONO K., DAVIS L. L. LIPOLYTIC ACTIVITY OF POST-HEPARIN PLASMA IN HYPERGLYCERIDEMIA. J Lipid Res. 1963 Jan;4:24–33. [PubMed] [Google Scholar]
  9. Hahn P. F. ABOLISHMENT OF ALIMENTARY LIPEMIA FOLLOWING INJECTION OF HEPARIN. Science. 1943 Jul 2;98(2531):19–20. doi: 10.1126/science.98.2531.19. [DOI] [PubMed] [Google Scholar]
  10. JEFFRIES G. H. The sites at which plasma clearing activity is produced and destroyed in the rat. Q J Exp Physiol Cogn Med Sci. 1954;39(4):261–270. doi: 10.1113/expphysiol.1954.sp001080. [DOI] [PubMed] [Google Scholar]
  11. KORN E. D. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem. 1955 Jul;215(1):1–14. [PubMed] [Google Scholar]
  12. KORN E. D., QUIGLEY T. W., Jr Lipoprotein lipase of chicken adipose tissue. J Biol Chem. 1957 Jun;226(2):833–839. [PubMed] [Google Scholar]
  13. LEQUIRE V. S., HAMILTON R. L., ADAMS R., MERRILL J. M. LIPASE ACTIVITY IN BLOOD FROM THE HEPATIC AND PERIPHERAL VASCULAR BEDS FOLLOWING HEPARIN. Proc Soc Exp Biol Med. 1963 Oct;114:104–107. doi: 10.3181/00379727-114-28598. [DOI] [PubMed] [Google Scholar]
  14. MCBRIDE O. W., KORN E. D. THE LIPOPROTEIN LIPASE OF MAMMARY GLAND AND THE CORRELATION OF ITS ACTIVITY TO LACTATION. J Lipid Res. 1963 Jan;4:17–20. [PubMed] [Google Scholar]
  15. MORRIS B., FRENCH J. E. The uptake and metabolism of 14C labelled chylomicron fat by the isolated perfused liver of the rat. Q J Exp Physiol Cogn Med Sci. 1958 Apr;43(2):180–188. doi: 10.1113/expphysiol.1958.sp001315. [DOI] [PubMed] [Google Scholar]
  16. ROBINSON D. S. CHANGES IN THE LIPOLYTIC ACTIVITY OF THE GUINEA PIG MAMMARY GLAND AT PARTURITION. J Lipid Res. 1963 Jan;4:21–23. [PubMed] [Google Scholar]
  17. ROBINSON D. S., FRENCH J. E. Heparin, the clearing factor lipase, and fat transport. Pharmacol Rev. 1960 Jun;12:241–263. [PubMed] [Google Scholar]
  18. ROBINSON D. S., HARRIS P. M. The production of lipolytic activity in the circulation of the hind limb in response to heparin. Q J Exp Physiol Cogn Med Sci. 1959 Jan;44(1):80–90. doi: 10.1113/expphysiol.1959.sp001378. [DOI] [PubMed] [Google Scholar]
  19. SELDINGER S. I. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta radiol. 1953 May;39(5):368–376. doi: 10.3109/00016925309136722. [DOI] [PubMed] [Google Scholar]
  20. SPITZER J. A., SPITZER J. J. Effect of liver on lipolysis by normal and post-heparin sera in the rat. Am J Physiol. 1956 Apr;185(1):18–22. doi: 10.1152/ajplegacy.1956.185.1.18. [DOI] [PubMed] [Google Scholar]
  21. SWANK R. L., LEVY S. W. Chylomicron dissolution; dosage and site of action of heparin. Am J Physiol. 1952 Oct;171(1):208–217. doi: 10.1152/ajplegacy.1952.171.1.208. [DOI] [PubMed] [Google Scholar]
  22. YOSHITOSHI Y., NAITO C., OKANIWA H., USUI M., MOGAMI T., TOMONO T. Kinetic studies on metabolism of lipoprotein lipase. J Clin Invest. 1963 May;42:707–713. doi: 10.1172/JCI104762. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES